Immune Privilege
Open Access
- 1 November 1999
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 190 (9) , 1197-1200
- https://doi.org/10.1084/jem.190.9.1197
Abstract
The concept of immune privilege refers to the observation that tissue grafts placed in certain anatomical sites, including the brain and eye, can survive for extended periods of time ([1][1]). Immune privilege is thought to reflect an evolutionary adaptation to protect vital structures from damageKeywords
This publication has 43 references indexed in Scilit:
- Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesisEuropean Journal of Immunology, 1999
- Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host DiseaseThe Journal of Experimental Medicine, 1999
- Overexpression of Natural Killer T Cells Protects Vα14-Jα281 Transgenic Nonobese Diabetic Mice against DiabetesThe Journal of Experimental Medicine, 1998
- MOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and FunctionAnnual Review of Immunology, 1997
- Immune privilege, T-cell tolerance, and tissue-restricted autoimmunityHuman Immunology, 1997
- Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouseEuropean Journal of Immunology, 1996
- CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological ToleranceImmunity, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis.The Journal of Experimental Medicine, 1995
- The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms.The Journal of Experimental Medicine, 1993